Module 04

Patient Flow

How many patients reach the eligible pool, and where do they leak?

71 in the library 5 markets 72h to deliverable

Commission Patient Flow See an example

What you receive

Working files, not a slide of prose.

Live Excel funnel model · PDF brief. Scope confirmed in 24 hours, delivered in 72.

In the library

Patient Flow the engine has already run.

United StatesUS NSCLC Patient Flow ModelIncidence-to-eligible NSCLC funnel by cohort with sourced conversion assumptions and a share waterfall.United StatesUS Myasthenia Gravis Patient Flow Model100,000-200,000 US gMG patients narrow to a 4,000-6,000 on-FcRn-therapy pool, and 1,200-2,100 of them remain inadequately controlled despite treatment.GCC (Gulf)GCC Myasthenia Gravis Patient Flow Model6,000-10,000 GCC gMG patients on the epidemiology estimate, of whom 200-300 are refractory and fewer than 50 are currently on biologic therapy.United KingdomUK Sickle Cell Disease Patient Flow ModelNewborn screening has been universal since 1999, so the UK's 15,000-17,000 diagnosed sickle cell patients are counted with confidence. They narrow to a 4,000-6,000-patient conventional-therapy gap and a separate 200-300-per-year gene-therapy-eligible pool.United KingdomUK Fabry Disease Patient Flow Model700-900 NHS-diagnosed Fabry patients split cleanly by therapy. Roughly 600 are on enzyme replacement and about 200, or 25%, on oral migalastat, with free NHS cascade testing adding 3-4 diagnosed relatives per index case.United StatesUS Spinal Muscular Atrophy Patient Flow Model8,000-10,000 US SMA patients split roughly 60/27/13/under 5 percent across Types 1-4. The 500-700-patient Zolgensma cohort is what this funnel validates against.United StatesUS Hereditary Angioedema Patient Flow ModelAn estimated 8,000-9,000 Americans live with hereditary angioedema. Just 35-40% receive any prophylaxis, leaving 2,500-4,000 patients who meet treatment criteria untreated, the funnel this model sizes precisely.GCC (Gulf)GCC Dravet Syndrome Patient Flow Model600-800 estimated GCC Dravet patients, fewer than 200 SCN1A-confirmed. A 200-400 near-term addressable cohort sits within that confirmed subset.United StatesUS PNH Patient Flow Model15,000-20,000 Americans carry a PNH clone, but only about 3,500 reach complement-inhibitor therapy. Up to 1,200 of them stay anaemic on it. This model sizes every gap in between.

All 71 in the library

Patient Flow: questions buyers ask

What is a patient flow model in pharma?

A patient flow model follows a population from incidence or prevalence through diagnosis, treatment and eligibility to the pool an asset's label can address, with a sourced conversion at each step.

How is a patient flow model different from a market forecast?

The patient flow model sizes the addressable pool and shows where patients leak from it. A forecast then applies uptake, share and price to that pool over time.

What format is the patient flow model delivered in?

A live Excel workbook with every conversion sourced and every assumption editable, and a PDF brief that explains the funnel.

Run Patient Flow on your asset.

Commission Book a scoping call